Drugs / Intrathecal morphine
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT03263689 | Mar 2014 → Jun 2016 | — | Mbarara University of Science and Technology | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT01312077 | Oct 2010 → Jun 2011 | — | Cork University Hospital | Unknown | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| — | NCT07584200 Comparator | Jun 2026 → Mar 2027 expected | osteoarthritis, hip | Poznan University of Medical Sciences | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Intrathecal morphine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03263689 ↗ |
| Known as | Morphine (intrathecal) | “Morphine (intrathecal)” NCT07584200 ↗ |
| Route | Intrathecal | “intrathecal morphine bolus 200 micrograms” NCT01312077 ↗ |